{"id":4686,"date":"2012-06-14T16:23:16","date_gmt":"2012-06-14T15:23:16","guid":{"rendered":"http:\/\/mileon.wordpress.com\/?p=4686"},"modified":"2012-06-14T16:23:16","modified_gmt":"2012-06-14T15:23:16","slug":"nuevos-anticoagulantes-en-la-enfermedad-tromboembolica-venosa","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/maitines\/2012-06-14\/nuevos-anticoagulantes-en-la-enfermedad-tromboembolica-venosa\/","title":{"rendered":"Nuevos anticoagulantes en la enfermedad tromboemb\u00f3lica venosa"},"content":{"rendered":"<p style=\"text-align:justify;\"><a href=\"https:\/\/mileon.files.wordpress.com\/2012\/06\/images2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-4687\" title=\"images\" src=\"https:\/\/mileon.files.wordpress.com\/2012\/06\/images2.jpg\" alt=\"\" width=\"167\" height=\"108\" \/><\/a>En la Sesi\u00f3n de Maitines del 5 de Junio se revis\u00f3 el tema de la utilidad de los nuevos anticoagulantes en el manejo de la ETEV. La Dra. Silvia Garc\u00eda, del S\u00ba de Neumolog\u00eda, repas\u00f3 las indicaciones de los nuevos anticoagulantes que se vienen presentando recientemente y de nuevos que est\u00e1n por aparecer. Adem\u00e1s de su uso en la profilaxis primaria en pacientes de riesgo y en enfermos con ACxFA, se plantea la posibilidad de utilizarlos en el tratamiento. Como siempre, al final surgen las mismas cuestiones: \u00bfson seguros? \u00bfqu\u00e9 pasa con el ant\u00eddoto? \u00bfse van a cumplir bien?&#8230;.<\/p>\n<p style=\"text-align:justify;\"><a href=\"https:\/\/mileon.files.wordpress.com\/2012\/06\/maitines2.pdf\">descargar Sesi\u00f3n aqu\u00ed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En la Sesi\u00f3n de Maitines del 5 de Junio se revis\u00f3 el tema de la utilidad de los nuevos anticoagulantes en el manejo de la ETEV. La Dra. Silvia Garc\u00eda, del S\u00ba de Neumolog\u00eda, repas\u00f3 las indicaciones de los nuevos anticoagulantes que se vienen presentando recientemente y de nuevos que est\u00e1n por aparecer. Adem\u00e1s de [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[715],"tags":[1031],"class_list":["post-4686","post","type-post","status-publish","format-standard","hentry","category-maitines","tag-silvia-garcia"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/4686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=4686"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/4686\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=4686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=4686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=4686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}